Quality prescribing for respiratory illness 2024 to 2027 - draft guidance: consultation
We are consulting on this draft guide which aims to optimise treatment outcomes in the management of respiratory illness. Produced by Scottish Government, NHS Scotland and Experts by Experience, it builds on the 2018 to 2021 strategy. It promotes person-centred care, the 7-Steps process for medicine reviews and shared decision-making.
9. Respiratory Prescribing Data for NHS Health Boards
This chapter contains some top-level prescribing information comparing NHS Boards. Chart 12 below highlights the cost per treated patient which has decreased by £8.00 in NHS Scotland between 2021 and 2022.
Generic Prescribing
National and local guidance promotes branded prescribing of all inhalers excluding salbutamol inhalers. This ensures that the correct inhaler device and product is given to the individual (for example, formulations of inhaled corticosteroids differ in potency). Chart 13 shows prescribing of generic inhalers across health boards, showing improvements across all boards.
Contact
Email: EPandT@gov.scot
There is a problem
Thanks for your feedback